These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1172656)

  • 1. Human complement C7 and C9 in fetal and newborn sera.
    Adinolfi M; Beck SE
    Arch Dis Child; 1975 Jul; 50(7):562-4. PubMed ID: 1172656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The analysis of the complement activation product SC5 b-9 is applicable in neonates in spite of their profound C9 deficiency.
    Høgåsen AK; Overlie I; Hansen TW; Abrahamsen TG; Finne PH; Høgåsen K
    J Perinat Med; 2000; 28(1):39-48. PubMed ID: 10765513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunochemical quantitation of serum complement components in SFD and AFD infants.
    Ueda H; Nakanishi A; Ichijo M
    Tohoku J Exp Med; 1980 Sep; 132(1):111-6. PubMed ID: 7209963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement system in human colostrum: presence of nine complement components and factors of alternative pathway in human colostrum.
    Nakajima S; Baba AS; Tamura N
    Int Arch Allergy Appl Immunol; 1977; 54(5):428-33. PubMed ID: 885627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormalities of complement and its components in patients with acute leukemia, Hodgkin's disease, and sarcoma.
    Lichtenfeld JL; Wiernik PH; Mardiney MR; Zarco RM
    Cancer Res; 1976 Oct; 36(10):3678-80. PubMed ID: 953991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypochlorite-induced alterations to canine serum complement.
    Boyer JT; Wyde P; Bier M
    Clin Exp Immunol; 1975 Aug; 21(2):345-50. PubMed ID: 1102168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental aspects of complement components in the newborn. The presence of complement components and C3 proactivator (properdin factor B) in human colostrum.
    Ballow M; Fang F; Good RA; Day NK
    Clin Exp Immunol; 1974 Oct; 18(2):257-66. PubMed ID: 4478765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The C5b-9 complex: subunit composition of the classical and alternative pathway-generated complex.
    Podack ER; Kolb WP; Muller-Eberhard HJ
    J Immunol; 1976 May; 116(5):1431-4. PubMed ID: 1270802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing of hemolytic complement components in domestic animals.
    Barta O; Hubbert NL
    Am J Vet Res; 1978 Aug; 39(8):1303-8. PubMed ID: 697137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [C6, C7, C8 and C9].
    Hatanaka M; Shimizu A
    Nihon Rinsho; 1999 Nov; 57 Suppl():71-4. PubMed ID: 10635778
    [No Abstract]   [Full Text] [Related]  

  • 11. Complement activation in fetuses: assessment by the levels of complement components and split products in cord blood.
    Miyano A; Nakayama M; Fujita T; Kitajima H; Imai S; Shimizu A
    Diagn Clin Immunol; 1987; 5(2):86-90. PubMed ID: 3497734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunoenzyme determination of the C5b-9 complex of the complement system].
    Rus H; Niculescu F; Cristea A; Vlaicu R
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1986; 31(1):35-40. PubMed ID: 3738363
    [No Abstract]   [Full Text] [Related]  

  • 13. The complement components C8 and C9 in sera and urines of patients with chronic membranoproliferative glomerulonephritis.
    Geiger H; Day NK; Good RA
    Clin Immunol Immunopathol; 1973 Jul; 1(4):463-71. PubMed ID: 4807981
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of aging on complement activity (CH50) and complement protein levels.
    Nagaki K; Hiramatsu S; Inai S; Sasaki A
    J Clin Lab Immunol; 1980 Jan; 3(1):45-50. PubMed ID: 7381926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement components in 100 newborns and their mothers determined by electroimmunoassay.
    Johnson U; Truedsson L; Gustavii B
    Acta Pathol Microbiol Immunol Scand C; 1983 Apr; 91(2):147-50. PubMed ID: 6349252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical significance of C6, C7, C9 and C1-INH analysis].
    Akagaki Y; Inai S
    Nihon Rinsho; 1990 Feb; 48 Suppl():662-5. PubMed ID: 2113138
    [No Abstract]   [Full Text] [Related]  

  • 17. [Concentration of C3 and C4 in the maternal blood and umbilical cord blood].
    Priolisi A; Liotta A; Damiani S
    Minerva Pediatr; 1977 Mar; 29(10):673. PubMed ID: 875935
    [No Abstract]   [Full Text] [Related]  

  • 18. [C6, C7, C8 and C9].
    Hatanaka M; Kitano E
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():90-3. PubMed ID: 20942009
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunologic tests: C6, C7, C8 and C9].
    Hatanaka M; Shimizu A
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():92-4. PubMed ID: 16111197
    [No Abstract]   [Full Text] [Related]  

  • 20. [Total hemolytic complement and C3 and C7 components in patients with paracoccidioidomycosis].
    Ribeiro MA; Fava Netto C
    Rev Inst Med Trop Sao Paulo; 1981; 23(3):106-10. PubMed ID: 7280476
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.